Sen. Grassley Wants "Independent" Drug Safety Function In FDA

Finance Committee chairman urges structural change at FDA during hearing on Merck's withdrawn COX-2 inhibitor Vioxx. Ranking Democrat Baucus says idea "makes sense;" FDA's Kweder tells the committee she personally has no objection to an independent safety office.